Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
Breast cancer is a heterogeneous disease encompassing a variety of entities with distinct
morphological features and clinical behaviors. Although morphology is often associated with …
morphological features and clinical behaviors. Although morphology is often associated with …
Triple-negative breast cancer: recent treatment advances
Triple-negative breast cancer (TNBC) is a breast cancer subtype renowned for its capacity to
affect younger women, metastasise early despite optimal adjuvant treatment and carry a …
affect younger women, metastasise early despite optimal adjuvant treatment and carry a …
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
The early detection of relapse following primary surgery for non-small-cell lung cancer and
the characterization of emerging subclones, which seed metastatic sites, might offer new …
the characterization of emerging subclones, which seed metastatic sites, might offer new …
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Introduction Triple negative breast cancer (TNBC) is a heterogeneous collection of
biologically diverse cancers, which contributes to variable clinical outcomes. Previously, we …
biologically diverse cancers, which contributes to variable clinical outcomes. Previously, we …
Triple-negative breast cancer: role of specific chemotherapy agents
SJ Isakoff - The Cancer Journal, 2010 - journals.lww.com
Cytotoxic chemotherapy remains the mainstay of treatment for triple-negative breast cancer
(TNBC) despite the promise of new targeted and biologic agents. Many studies have shown …
(TNBC) despite the promise of new targeted and biologic agents. Many studies have shown …
[HTML][HTML] Triple negative breast cancer: a mountain yet to be scaled despite the triumphs
Simple Summary Triple-negative breast cancer (TNBC) is a highly aggressive subtype of
breast cancer that cannot be treated with endocrine therapy and Her2-targeted therapy …
breast cancer that cannot be treated with endocrine therapy and Her2-targeted therapy …
[PDF][PDF] Triple negative breast cancer-prognostic factors and survival
T Ovcaricek, SG Frkovic, E Matos, B Mozina… - Radiology and …, 2011 - sciendo.com
Background. Triple negative breast cancer (TNBC) is defined by a lack of expression of both
estrogen (ER) and progesteron (PgR) receptors as well as human epidermal growth factor …
estrogen (ER) and progesteron (PgR) receptors as well as human epidermal growth factor …
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
Introduction Triple negative breast cancer (TNBC) has a poorer survival, despite a higher
response rate to neoadjuvant chemotherapy. The purpose of this study was to identify the …
response rate to neoadjuvant chemotherapy. The purpose of this study was to identify the …
[HTML][HTML] Management of triple negative breast cancer
Triple negative breast cancer (TNBC) accounts for approximately 15% of breast cancer
cases. TNBC is an immunohistochemically defined subtype, with significant diversity within …
cases. TNBC is an immunohistochemically defined subtype, with significant diversity within …
Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the US-a SEER analysis
Background Recent reports suggest increase in estrogen receptor (ER), progesterone
receptor (PR) negative breast cancer yet little is known about histology or receptor status of …
receptor (PR) negative breast cancer yet little is known about histology or receptor status of …